SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
43
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ormat Technologies, Inc. (ORA) & Lead Plaintiff Deadline – August 10, 2018

NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ormat Technologies, Inc. ("Ormat" or the "Company") (NYSE: ORA ) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ormat securities between August 8, 2017 and May 15, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/ora .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were errors in the income tax provision primarily relating to Ormat’s valuation allowance based on its ability to utilize foreign tax credits in the U.S. prior to their expiration; (2) Ormat netted certain deferred income tax assets and deferred income tax liabilities across different tax jurisdictions that are not permitted to be netted pursuant to United States generally accepted accounting principles; (3) Ormat’s internal controls over financial reporting were ineffective; (4) Ormat would need to restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements; and (5) as a result, defendants’ statements about Ormat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.

On May 11, 2018, Ormat disclosed that the Company was delaying the filing of its Quarterly Report for the period ended March 31, 2018 with the U.S. Securities and Exchange Commission, stating that “management has identified an error in the Company's financial statement presentation of deferred income tax assets and deferred income tax liabilities that affects the Company's balance sheets in previous reporting periods.”  Ormat further disclosed that “[t]he Company is evaluating the impact of this error on its consolidated financial statements and the extent to which the Company's annual and quarterly consolidated financial statements filed in previous periods require revision or amendment.”  On this news, Ormat's share price fell $3.58, or over 6%, over two consecutive trading days to close at $52.77 on May 14, 2018. 

Then, on May 16, 2018, Ormat announced that the Company “will restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements,” and stated that “investors should no longer rely upon the Company's previously issued financial statements for [these] periods . . . , earnings releases for these periods, and other communications relating to these financial statements.”  On this news, Ormat's share price fell $0.67, or 1.26%, to close at $52.35 on May 16, 2018.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/ora or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Ormat you have until August 10, 2018 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Expats Delight in Culture and Culinary Wonders of Lanxi

Updated Category News Views 65

Discovering the Hidden Treasures of Lanxi Lanxi, a delightful city located in East China's Zhejiang province, stands out as a cultural landmark and a vibrant commercial center. Recently, a group of international visitors had the chance to delve into its rich history, traditional arts, and delicious cuisine during their stay. Engaging Cultural Experiences The adventure...

Continue Reading
JPMorgan Asset Management's Major Stake in OSB Group Plc

Updated Category News Views 116

Understanding Major Holdings in OSB Group Plc Major shareholding notifications are vital for investors and stakeholders as they shed light on the dynamics of ownership and influence within a company. Recently, JPMorgan Asset Management Holdings Inc. has crossed significant thresholds in its holding in OSB Group Plc, revealing important insights into its investment...

Continue Reading
Why Pfizer Is the Healthcare Stock You Should Invest In

Updated Category News Views 83

Understanding the Healthcare Investment Landscape When people think of income investments, they often overlook the healthcare sector due to its average standing in S&P 500 rankings related to dividend yields. Despite being the eighth-ranked sector, several healthcare stocks defy this norm by offering substantial dividends, making them compelling options for investors. In...

Continue Reading
Bruno Marc's Crafture Leather Collection: Elevate Your Style

Updated Category News Views 131

Introducing the Crafture Leather Collection by Bruno Marc A new era of men’s premium leather dress shoes has arrived with the launch of Bruno Marc's Crafture Leather Collection. This innovative lineup is tailored for comfort, style, and everyday wear, crafted without the luxury markup often seen in high-end footwear. By merging traditional elegance with modern...

Continue Reading
Innovative Cancer Research from RWJBarnabas Health Surfaces

Updated Category News Views 311

Significant Advances in Oncology Research by RWJBarnabas Health Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute are set to present significant findings at an upcoming major oncology event. This meeting serves as a platform for showcasing progressive research aimed at transforming cancer care. The extensive cancer research program highlights...

Continue Reading